Quantification of gadolinium in nephrogenic systemic fibrosis: Re-examination of a reported cohort with analysis of clinical factors - 24/04/13
Reprint requests: Whitney A. High, MD, MEng, Assistant Professor, Dermatology & Pathology, University of Colorado Health Sciences Center, PO Box 6510, Mail Stop F703, Aurora, CO 80045.Abstract |
Background |
Nephrogenic systemic fibrosis (NSF) has been associated with exposure to gadolinium-based contrast agent (GdCA) used in medical imaging.
Objective |
We sought to quantify levels of gadolinium in affected skin of patients with NSF and correlate the levels to clinical and laboratory parameters.
Methods |
Skin biopsy specimens were analyzed using inductively coupled plasma mass spectroscopy (ICP-MS) and the micrograms of gadolinium per gram (μg/g) of dry tissue were determined. Clinical and laboratory data were obtained through retrospective chart review. Pearson correlation coefficients were used to correlate tissue gadolinium levels with various parameters.
Results |
Six patients from a prior cohort were analyzed for gadolinium in affected skin. The mean amount of gadolinium in affected skin of NSF patients was 320.1 μg/g. No gadolinium was found in limited control tissue from patients unexposed to GdCA or in patients exposed to such agents, but without disease. Higher levels of gadolinium in skin correlated with younger age, lower body weight, lower corrected serum calcium levels, and lower erythropoietin dosing.
Limitations |
The study was limited by the small number of cases and by the retrospective nature of the data and skin samples.
Conclusion |
Gadolinium is present in substantial amounts within the skin of patients with NSF. Quantification of gadolinium in tissue using ICP-MS may facilitate our understanding of the disease.
Le texte complet de cet article est disponible en PDF.Abbreviations used : EDS, EM, GdCA, ICP-MS, NSF
Plan
| Dr High’s work is supported, in part, by a Career Development Award in Medical Dermatology from Dermatology Foundation. No other financial support was received or was necessary for the study. |
|
| Conflicts of interest: None declared. |
Vol 59 - N° 2
P. 218-224 - août 2008 Retour au numéro
Article précédent
- Notification of Change in JAAD CME Article and Exam Credit
- Delayed patch test reading after 5 days: The Mayo Clinic experience
- Mark D.P. Davis, Ketaki Bhate, Audrey L. Rohlinger, Sara A. Farmer, Donna M. Richardson, Amy L. Weaver
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?